OGNOrganon & Co.

NYSE organon.com


$ 18.83 $ 0.22 (1.18 %)    

Wednesday, 01-May-2024 15:59:55 EDT
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 18.83
$ 18.65
$ 18.83 x 100
$ 18.89 x 100
$ 18.60 - $ 19.12
$ 10.67 - $ 23.02
2,396,025
na
4.83B
$ 0.82
$ 4.72
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-26-2024 12-31-2023 10-K
2 11-03-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-05-2023 03-31-2023 10-Q
5 02-27-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-06-2022 03-31-2022 10-Q
9 03-21-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 06-21-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-organon-raises-price-target-to-24

Piper Sandler analyst David Amsellem maintains Organon (NYSE:OGN) with a Overweight and raises the price target from $22 to ...

 wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

 new-york-attorney-general-urges-fda-action-on-widely-used-asthma-drugs-concerns-over-pediatric-safety

The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used ...

 first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

 organon-announces-hadlima-adalimumab-bwwd-has-been-exclusively-selected-by-us-department-of-veterans-affairs-replacing-humira-on-its-national-formulary

HADLIMA is an FDA-approved biosimilar to HUMIRA for the treatment of specific autoimmune or autoinflammatory conditions such as...

 why-is-women-health-focused-organon-stock-trading-higher-on-thursday

Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, drive...

 why-herbalife-shares-are-trading-lower-by-around-36-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

 reliance-steel--aluminum-posts-upbeat-earnings-joins-jfrog-applovin-shake-shack-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

 organon-q4-adjusted-eps-088-beats-083-estimate-sales-160b-beat-155b-estimate

Organon (NYSE:OGN) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.83 by 6.02 pe...

 earnings-scheduled-for-february-15-2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

 organons-earnings-a-preview
Organon's Earnings: A Preview
02/14/2024 15:01:04

 did-you-miss-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurate-analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

 beat-inflation-with-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurate-analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

 why-organon--co-stock-popped-today

Organon & Co. (NYSE: OGN) shares traded higher on Wednesday after the company announced the availability of XACIATO 2% by p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION